4//SEC Filing
Raptor Pharmaceutical Corp 4
Accession 0001140361-13-036314
CIK 0001070698operating
Filed
Sep 17, 8:00 PM ET
Accepted
Sep 18, 5:40 PM ET
Size
17.2 KB
Accession
0001140361-13-036314
Insider Transaction Report
Form 4
SAGER ERICH
Director
Transactions
- Sale
Common Stock
2013-09-16$14.21/sh−17,000$241,517→ 130,727 total
Holdings
- 30,000
Stock options (right to buy)
Exercise: $2.97From: 2011-03-01Exp: 2020-10-11→ Common Stock (30,000 underlying) - 50,000
Stock options (right to buy)
Exercise: $5.49From: 2012-12-25Exp: 2022-09-24→ Common Stock (50,000 underlying) - 17,485
Stock options (right to buy)
Exercise: $2.57From: 2007-12-14Exp: 2017-06-13→ Common Stock (17,485 underlying) - 174,843
Stock options (right to buy)
Exercise: $2.57From: 2006-11-25Exp: 2016-05-25→ Common Stock (174,843 underlying) - 13,203
Stock options (right to buy)
Exercise: $2.02From: 2010-03-09Exp: 2020-03-08→ Common Stock (13,203 underlying) - 90,000
Stock options (right to buy)
Exercise: $3.54From: 2010-11-22Exp: 2020-11-21→ Common Stock (90,000 underlying) - 90,000
Stock options (right to buy)
Exercise: $5.13From: 2012-03-22Exp: 2021-09-21→ Common Stock (90,000 underlying) - 30,000
Stock options (right to buy)
Exercise: $5.13From: 2011-12-22Exp: 2021-09-21→ Common Stock (30,000 underlying)
Footnotes (10)
- [F1]Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person on August 13, 2013.
- [F10]The shares listed as owned in column 9 represent the total shares for each respective option. Previous reports reflected aggregate amounts of option shares in column 9. The holding lines included on this Form 4 are included solely to correct the breakdown of shares among various stock options and are not meant to reflect any change in beneficial ownership of option shares other than those reported as a transaction on this Form 4.
- [F2]This transaction was executed in multiple trades at prices ranging from $13.95 to $14.37. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide, upon request, to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- [F3]Stock options vest 6/48ths on the six month anniversary of grant date and 1/48th per month thereafter.
- [F4]Stock options vest 25% quarterly.
- [F5]Options vest 6/36ths on the six month anniversary of grant date and 1/36th per month thereafter.
- [F6]Stock options vest starting on September 1, 2010, 6/48ths on March 1, 2011 and 1/48th per month thereafter.
- [F7]Stock option vests 25% immediately and 75% pro rata over 36 months.
- [F8]Options vest 6/48ths immediately and 1/48th per month thereafter.
- [F9]Fully vested and exercisable.
Documents
Issuer
Raptor Pharmaceutical Corp
CIK 0001070698
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001070698
Filing Metadata
- Form type
- 4
- Filed
- Sep 17, 8:00 PM ET
- Accepted
- Sep 18, 5:40 PM ET
- Size
- 17.2 KB